Gas plasmas consisting of ionized air at ambient temperature can disinfect contact lenses in 2 minutes, according to Michael G. Kong of Old Dominion University in Norfolk, Va., and his collaborators at several universities in the United Kingdom. The procedure is effective against bacteria, spores, fungi, and even cysts of Acanthamoeba protozoans, which are notoriously diffıcult to kill or remove from such surfaces. Thus, treating lenses with such plasmas will likely be effective in preventing keratitis, a serious inflammation of the cornea that can lead to blindness. Details appeared 18 March 2016 in Applied and Environmental Microbiology (doi:10.1128 /AEM.03863-15) .
"The results presented are an important advance, since protozoans, particularly in the cyst phase, show strong resistance to many treatments," says Tony Murphy of the Commonwealth Scientifıc and Industrial Research Organization (CSIRO) in Canberra, Australia. "Many commercially available contact lens care solutions are ineffective against Acanthamoeba, and require long exposure times of 6 hours or more to eradicate common bacteria and fungi." Moreover, cysts can remain viable for decades, withstanding chemical assaults and desiccation.
The gas plasma technology is surprisingly simple and readily adaptable for use in treating contact lenses. In brief, it requires placing two electrodes that lie above the fluid line in a small vessel, connecting them to an electric power source, and then generating charged particles in the air space above the fluid. The particles react with air molecules to produce short-lived reactive oxygen species, including superoxide and hydrogen peroxide, to oxidize and otherwise damage molecules vital to the survival of the pathogens. Ultraviolet radiation and electric fıelds may also play a role in damaging the target cells, according to Murphy.
The electric power required to run that reaction is a low 50 mW/cm 2 , according to John Verboncoeur of Michigan State University, East Lansing. "You could run it off of battery power," he says. "That would probably be easier to carry and more portable than [contact lens] solution."
The realization that such plasmas could kill bacteria dates to the 1930s, but it was in the 1990s that the fıeld of plasma medicine took off, according to Kong. Other applications include inactivating microbes on surgical equipment, killing cancer cells, enhancing wound healing, and treating psoriasis and topical fungal infections, he says. In the food industry, gas plasmas can be used to reduce levels of pathogens on fresh vegetables and fruits.
Gas plasmas can disinfect small objects such as contact lenses within 10 minutes, in contrast to the standard 6 hours that is recommended for daily treatment with various types of cleansing solutions. Although powerful, the gas plasma treatment does not damage lenses. "We looked at them under the microscope, and found neither discoloration nor scratching," Kong says.
An estimated 39.2 million cases of keratitis occur annually in North America, at a cost of roughly $175 million. Many different types of microorTraditional methods of cleaning contact lenses may yet be supplanted by treating the lenses with cold gas plasmas, which can work in minutes and protect more effectively against organisms like Acanthamoeba. (Image © iStockphoto/marinazb.) ganisms can cause keratitis, including bacteria, fungi, protozoans, and viruses. Although protozoan-associated keratitis is rare, 85% of such cases occur among individuals who wear contact lenses.
David Holzman is a freelance writer in Lexington, Mass.
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US Policy Proposals for Gain-of-Function Research Raise Global Questions Jeffrey L. Fox
Offıcials seem poised to accept the updated broad framework for assessing gain-of function (GoF) research proposals that the National Science Advisory Board for Biosecurity (NSABB) developed last year, making it the basis for federal policy. As part of a painstaking vetting of those proposals, NSABB members presented their draft guidance publicly under the auspices of the National Academy of Sciences (NAS) in Washington, D.C., in March, asking for feedback from scientifıc and science policy experts.
Controversy over GoF research dates back several years to when federal offıcials imposed a temporary halt to specifıc types of experiments involving the influenza and MERS-CoV viruses. As part of its broad response to those events, NSABB worked with Gryphon Scientifıc of Takoma Park, Md., asking the company to conduct an extensive risk-benefıt analysis of GOF research. The board also commissioned a white paper reviewing the ethics of GOF research as well as a separate review of the "policy landscape."
Meanwhile, the company's 1,000-page risk-benefıt report considers many different scenarios that could lead to increased risks from conducting such research, according to Samuel Stanley of Stony Brook University in Stony Brook, N.Y., who chairs NSABB. From those analyses, NSABB came to several key fındings and issued a set of recommendations that narrow the scope and more precisely defıne just what GOF research proposals should trigger special scrutiny, he says. To this point, the review process is mainly abstract, and lends itself to being described as steps in a block diagram. In reality, that review process and questions about it prove messier and more contentious than the compact block diagram suggests.
One major focal point for debate is the three criteria cited for identifying GOF research proposals that deserve special scrutiny and, potentially, should not be pursued. Simply put, they are changes to an already notoriously problematic pathogen that might render it even more virulent, more transmissible, and potentially capable of spreading in pandemic fashion because it might overcome available public health countermeasures.
Questions about that third criterion and also whether all three attributes should be present to raise warning flags remain a central part of the ongoing debate. "What's important is what you end up with," says NSABB member Kenneth Berns of the University of Florida, Gainesville. "The real concern is the potential for its causing a pandemic."
However, others pointed out that safety issues in overlapping areas of bi-
MINITOPIC
Microbiology Policy Bulletin Board
Recent developments involving microbiology and related science policy matters include:
• Florida as a way of curbing this vector of the Zika, dengue, and chikungunya viruses were given "a preliminary finding of no significant impact, or FONSI," by officials of the US Food and Drug Administration last March. Oxitec is a subsidiary of Intrexon Corporation of Germantown, Md.
• Ending hepatitis B and C infections would save 20,000 American lives per year, a public health undertaking that can be met mainly by preventing new cases, according to a report, "A National Strategy on the Elimination of Hepatitis B and C-Phase 1," released last April by the National Academies of Sciences, Engineering, and Medicine in Washington, D.C. Copies of the report are available from the National Academies Press (http://www.nap .edu).
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